טוען...
Bayesian Framework to Augment Tumor Board Decision Making
Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a consensus on an optimal therapeutic strategy. However, many oncologists lack access to a tumor board, and m...
שמור ב:
| הוצא לאור ב: | JCO Clin Cancer Inform |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer Health
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8240793/ https://ncbi.nlm.nih.gov/pubmed/33974446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.20.00085 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|